To access the effectiveness of radiofrequency myolysis (RFM) in women with midline dysmenorrhea. Methods: We designed RFM in two ways laparoscopic RFM (LRFM), vaginal ultrasound-guided RFM (URFM). One hundred and thirty-two patients were in the LRFM group and, 140 patients were in the URFM group. Results: Upon receipt of surgery, both the LRFM and the URFM groups demonstrated a significant decrease (P < 0.001) in the mean pain score when compared to those before and after surgery.
Dysmenorrhea, painful menstrual cramps of uterine origin, is one of the most common gynecologic complaints, ranging between 43% and 90%. 1, 2 Since the 1960s, medical therapy with nonsteroidal anti-inflammatory drugs (NSAIDs) and oral contraceptives with the addition of danazol and gonadotropin-releasing hormone (GnRH) has been treatment of choice for chronic pelvic pain and dysmenorrheal. 3 However, rapid regrowth of the myomas to their original size has been reported to cause the recurrence of symptoms within a few months after the discontinuation of hormone treatment. 4 Furthermore, GnRH agonists can obliterate the myomamyometrial interface and as a result enucleation of myomas becomes more difficult. 5 Hormone therapy has been limited to premenopausal use only.
Medical treatments can be effective in some patients, there is still a 20 to 25% failure rate, in which case surgery becomes a treatment option. 6 Therefore, surgical intervention has been considered a good method to treat patients who have intractable dysmenorrhea and pelvic pain. Also, it is considered the minimally invasive method of treatment for premenopausal women of severe dysmenorrhea.
Laparoscopic uterine nerve ablation (LUNA) and lapa- In this study, radiofrequency myolysis (RFM) was performed on patients with midline dysmenorrhea.
We designed RFM in two ways laparoscopic RFM (LRFM), vaginal ultrasound-guided RFM (URFM).
The aim of the present study was to access the effectiveness of LRFM and URFM in patients with midline dysmenorrhea.
Materials and Methods

Study population
The study was conducted in the Department of Obstetrics Two hundred and seventy-two patients who had undergone surgery were prospectively surveyed regarding dysmenorrhea before and 1 year after RFM.
Informed consent was obtained. All patients were informed the risks and benefits of laparoscopic RFM. Before RFM as well as 1 year after surgery, they all completed a questionnaire that requested information on the severity of dysmenorrhea on a 0 to 4 pain score, which was similar to that devised by Chen.
8,9
Severity of dysmenorrhea in all patients was scored in a 5-point scale ranging from 0 to 4 (i.e., 0 = no pain, 1 = mild pain requiring no medication, 2 = moderate pain responding to mild pain relievers, 3 = severe pain necessitating potent pain relievers, and 4 = incapacitating pain unresponsive to potent pain relievers).
We didn't administer GnRH analogs to the patients in the study. And we treated women whom they don't want to have a baby anymore; because of not being proven the relationship between RFM, with pregnancy and side effects.
All examinations and procedures were performed by one gynecologist. 
Statistical analysis
In this study, the Student's t test, the Mann-Whitney U test and chi-square test were employed to compare age, operation time, length of hospitalizaton and postoperative dysmenorrhea pain score whenever appropriate. 
Results
We designed a prospective study and used a zero-to-4 pain score system to evaluate 272 patients before and after RF myolysis. The classification of patients are shown in Table 1 for the LRFM and the URFM groups. Table 2 shows no significant difference on the hospitalization length and post operative pain score between two groups. The mean length of hospital stay (± standard deviation [SD]) was 1.34 ± 0.27, 1.53 ± 0.85, respectively (P < 0.808). Most women were discharged on the day after RFM.
The pain scale scores before and after RF myolysis are reported in Table 3 . The mean (± SD) post-operative pain score for dysmenorrhea was 0.83 ± 0.53 (URFM), 0.32 ± 0.78 (LRFM). In all groups, a significant difference was found in terms of pain scores for dysmenorrheal (P < 0.001) before and after RFM. No patient reported a change in the postoperative pain score during follow-up. But the mean operation time was shorter in the URFM group, compared to the LRFM group.
The comparison of complications on both groups are expressed in Table 4 . No major complications occurred during or immediately following the operation. Only the increased vaginal discharge and abdominal pain were The operative time, hospital stay and post-operative pain score are expressed as mean ± standard deviation (SD) LRFM: laparoscopic radiofrequency myolysis, URFM: ultrasoundguided radiofrequency myolysis Pain score for dysmenorrhea is expressed as mean pain score ± standard deviation (SD) Statistical significant difference exists when P value < 0.05 LRFM: laparoscopic radiofrequency myolysis, URFM: ultrasoundguided radiofrequency myolysis statistically different in the two groups (P = 0.006, P = 0.000).
Discussion
Dysmenorrhea is a common gynecologic complaint because lasts until menopause. Previous studies have revealed that presacral neurectomy (PSN) provides an effective and relatively safe treatment for women with midline dysmenorrheal.
10~12
An often-ignored procedure is interruption of uterosacral nerves. It was first described by Ruggi 13 We designed a prospective study and used a zero-to-4 pain score system to evaluate 272 patients before and after RFM. No patient had intraoperative or long-term complications.
We conclude that dysmenorrheal statistically significantly When a patient requires surgical treatment for chronic midline pelvic pain or severe dysmenorrhea, LRFM is an al ternative choice. It is relatively safe, simple to perform and satisfactory. LRFM is an alternative choice because it is relatively safe and, simple to perform and moreover, it is satisfactory. A larger series of patients and precise methodology, including a more detailed pain score system of inclusion criteria, nonetheless, are necessary to fully evaluate the efficacy of the LRFM procedure.
